Importantly, the clinical sample analysis strongly supports the existence of the proposed signaling mechanism in DLBCL cases, especially in ABC-type DLBCL, which harbors constitutive NF-κB activation30. This evidence concerns the gene NFKB1 and diffuse large B-cell lymphoma.